Literature DB >> 16947008

Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery.

Jun Ho Lee1, Keun Won Ryu, Jin-Hee Lee, Sook Ryun Park, Chan Gyoo Kim, Myoung Cheorl Kook, Byung-Ho Nam, Young-Woo Kim, Jae-Moon Bae.   

Abstract

BACKGROUND: This study was conducted to evaluate the leaning curve of D2 lymph node dissection for patients with gastric cancer in a high-volume center.
METHODS: The authors prospectively reviewed the data of all patients who underwent total gastrectomy with D2 lymph node dissection during a 4-year period. Retrieved lymph node number was used as a surrogate marker of oncological outcome. The retrieved lymph node number cut-off value required for satisfactory D2 lymph node dissection was defined as >25. Cumulative sum analysis was used to examine the learning curves of individual surgeons at target accuracy rates of 85%, 90%, 92.5%, 95%, and 98%.
RESULTS: Two junior staff surgeons performed 198 curative-intent total gastrectomies with D2 lymph node dissections during the study period; their success rates exceeded 90%. Operating time decreased with operative experience (Pearson correlation coefficient = -0.515, P < 0.001). The learning period for total gastrectomy with D2 lymph node dissection for these two junior members of staff was calculated as 23-35 cases, presuming a 92.5% success rate.
CONCLUSIONS: The current study suggests that the surgical learning period for D2 lymph node dissection extends to at least 23 cases or 8 months. In clinical trials containing gastric cancer surgery, the learning curve for qualified surgery from the standpoint of oncological outcome should be considered to minimize bias due to surgeon-associated factors.

Entities:  

Mesh:

Year:  2006        PMID: 16947008     DOI: 10.1245/s10434-006-9050-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

Review 1.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 2.  An evidence-based review of the surgical treatment of gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Sam S Yoon
Journal:  J Gastrointest Surg       Date:  2011-03-12       Impact factor: 3.452

3.  The learning curve associated with laparoscopic total gastrectomy.

Authors:  Do Hyun Jung; Sang-Yong Son; Young Suk Park; Dong Joon Shin; Hye Seong Ahn; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  Gastric Cancer       Date:  2014-12-07       Impact factor: 7.370

4.  Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matched-pair analysis.

Authors:  Shigeru Tsunoda; Hiroshi Okabe; Kazutaka Obama; Eiji Tanaka; Masatoshi Akagami; Yousuke Kinjo; Yoshiharu Sakai
Journal:  Surg Today       Date:  2013-03-06       Impact factor: 2.549

5.  Extended lymphadenectomy in gastric cancer is crucial.

Authors:  Lorenzo Ferri
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

6.  Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.

Authors:  Fang-Hai Han; Sheng-Ning Zhou; Hong-Ming Li; Yu-Long He; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

7.  Association between the participation of board-certified surgeons in gastroenterological surgery and operative mortality after eight gastroenterological procedures.

Authors:  Hiroyuki Konno; Kinji Kamiya; Hirotoshi Kikuchi; Hiroaki Miyata; Norimichi Hirahara; Mitsukazu Gotoh; Go Wakabayashi; Tetsuo Ohta; Norihiro Kokudo; Masaki Mori; Yasuyuki Seto
Journal:  Surg Today       Date:  2016-09-29       Impact factor: 2.549

8.  Race and correlations between lymph node number and survival for patients with gastric cancer.

Authors:  Rebecca Nelson; Eun Bi Ko; Amanda Arrington; Wendy Lee; Jae Kim; Julio Garcia-Aguilar; Joseph Kim
Journal:  J Gastrointest Surg       Date:  2013-01-04       Impact factor: 3.452

9.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

10.  Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data.

Authors:  Felix H Lui; Bertrand Tuan; Sara L Swenson; Robert J Wong
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.